30,000

Registrants

550

Chinese Exhibitors

50

Oversea Exhibitors

800+

Speakers

10,000

1V1 Partnering

About BIOCHINA2024(EBC)

Originated from 2016, BIOCHINA2024(EBC) is a convention with a scale of more than 20,000 participants. Associating with the scientific research, biotech and biopharma companies, government regulation agencies, and clinical institutions, the convention connected each sectors together for advancing the bio ecosystem in China. “Exhibition-Conference-Event”, are the three major components of BIOCHINA2024(EBC) - The exhibition covers raw materials, reagents, consumables, instruments and equipment, and technical services. The conference covers antibody drugs, cell and gene therapy, nucleic acid drugs, IVD, vaccine, and other innovative development categories. BIOCHINA2024(EBC) initiated with entrepreneurs, investors, scientists, and clinical experts to spreading their thoughts and inspirations of new technologies and projects.

Conference Forum

More >

Antibody drug

ADC & PDC & XDC

Cell and Gene Therapy

Nucleic Acid Drug

Stem Cell

Vaccine

Small Molecule

Synthetic Biology

Previous Session of Honourary Chairman

Wei Yuquan

Academician

Chinese Academy of Sciences

Deng Zixin

Academician

Chinese Academy of Sciences

Chen Kaixian

Academician

Chinese Academy of Sciences

Previous Session of Executive Chairman

Wang Yue

Managing Director

China Society for Drug Regulation

Previous Session of Expert Committee

Zhang Lianshan

Vice President & President of Global R&D

Hengrui Pharmaceuticals

Fang Jianmin

CEO & CSO

RemeGen

Li Ning

General Manager

Junshi Pharma

Zhang Wenjie

Chairman, Executive Director, CEO

Henlius

Gong Zhaolong

Chairman & CEO

3D Medicines

Tao Weikang

Via president & General manager of Innovative Drug

Qilu pharmacentical

Xu Ting

President

Alphamab Oncology

Sui Ziye

Executive Director and General Manager

Lepu Biopharma

Yang Jianxin

CEO

CStone Pharmaceuticals

Yang Qing

Co-CEO

WuXi AppTec

Li Yiping

CEO

JW Therapeutics

Huang Hai

CEO & Executive President

Fosun Kite

Huang Ying

CEO

Legend Biotech

Li Zonghai

Co-founder & CEO & CSO

CARsgen Therapeutics

Li Bin

Founder, Chairman & CEO

Neurophth

Wang Jianxiang

Deputy Director, Hematology Hospital, Institute of Hematology

Chinese Academy of Medical Sciences

Liang Zicai

CEO

Ribo Life Science

Ying Bo

Founder & CEO

ABOGEN

Lu Yang

CEO

Sirnaomics

Wang Zefeng

Scientific Founder

CirCode

Wang Hualiang

President

Shanghai Institute of Experimental Medicine

Cai Daqing

Founding Managing Partner

Sherpa Healthcare Partners

Wang Junfeng

Co-Chief Investment Officer & Managing Director

Legend Capital

Previous Session of Exhibition Hall

Hall B3 Technical Services Hall Hall C3 Outstanding Brands Hall Hall D3 Raw materials, Reagents and Consumables Hall Hall E Instruments and Equipment Hall

Previous Session of Official Partner

Previous Session of Gold Sponsor

Previous Session of Silver Sponsor

Audience Registration

18516293597

liuwenjuan@enmore.com

Exhibition Enquires

18516293589

assistant_healthcare@enmore.com

Media Cooperation

13585745181

karissaling@enmore.com

Purchasing Services

18512118231

zhouzhiqiang@enmore.com

BIOCHINA2024(EBC)

Copyright © ENMOREShanghai ICP No. 2021023038-7

Shanghai Public Security No. 31010502006254